In support of this hypothesis, gene-based therapies using GAD1 to modulate neuronal signaling are being used to treat patients with Parkinson’s disease and similar approaches could be evaluated in patients with ALS 36,37. The gene discussed is GAD1; the disease is Parkinson disease.